Bone Marrow Transplant Database
- Result Type
- clinical trial
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Status: Active, Recruiting
Currently displaying10Showing results
- Results per page
- Currently displaying10Results per page
- Display30Results per page
- Display50Results per page
11results found for:
City of Hope 96144 Molecular Genetics Studies of Cancer Patients and Their Relatives
- Result Type
- clinical trial
The purpose of this study is to find out how genetics, biologics and behavior might contribute to
Status: Active, Recruiting
Commands
- Result Type
- clinical trial
ACE-536 VS.Epoetin Alfa for the TX of Anemia Due to IPSS-R Very Low,Low or Intermediate Risk MDS in ESA Naïve Subjects Who Require RBC Transfusions
Status: Active, Recruiting
Connect
- Result Type
- clinical trial
Connect® MDS/AML Disease Registry
Status: Active, Recruiting
Locally Advanced (Panova-3)
- Result Type
- clinical trial
Randomized, open-label study of TTFields, 150kHz concomitant with gemcitabine and nab-paclitaxel for treatment of locally-advanced pancreatic adenocarcinoma
Status: Active, Recruiting
Metastatic (AstraZeneca D533AC00001 MONETTE)
- Result Type
- clinical trial
AstraZeneca D533AC00001 MONETTE: A Randomised, Open-Label, Phase 2 Study of Ceralasertib Monotherapy and Ceralasertib plus Durvalumab in Patients with Unresect
Status: Active, Recruiting
Myelofibrosis (INCB 50465-304)
- Result Type
- clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of the PI3Kd Inhibitor Parsaclisib Plus Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal
Status: Active, Recruiting
Myelofibrosis (INCB 50465-313)
- Result Type
- clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3Kd Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibros
Status: Active, Recruiting
Pediatric COG Long Term Follow Up (COG_ALTE05N1)
- Result Type
- clinical trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Active, Recruiting
Relapesed/Refractory (MAGNIFY)
- Result Type
- clinical trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma
Status: Active, Not Recruiting
Currently displaying10Showing results
- Results per page
- Currently displaying10Results per page
- Display30Results per page
- Display50Results per page